Phase 3 Multicenter Comparative Study to Confirm Safety and Effectiveness of the F(ab)2 Antivenom Anavip.

This study is currently recruiting participants.

Study NCT00636116 Information provided by Instituto Bioclon S.A. de C.V.

First Received: March 11, 2008 Last Updated: November 12, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	March 2010
Estimated Primary Completion Date:	November 2009 (Final data collection date for primary outcome measure)